Get Premium to unlock powerful stock data
NAS:JNCE (USA)  
Jounce Therapeutics Inc logo

Jounce Therapeutics Inc

$ 2.80 -0.26 (-8.5%) 10:08 PM EST
P/E:
At Loss
P/B:
0.77
Market Cap:
$ 144.69M
Enterprise V:
$ 2.08M
Volume:
1.13M
Avg Vol (2M):
348.73K
Also Trade In:
Volume:
1.13M
Market Cap $:
144.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
348.73K
Enterprise Value $:
2.08M
PB Ratio:
0.77
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Jounce Therapeutics Inc
NAICS : 325412 SIC : 2834
780 Memorial Drive, Cambridge, MA, USA, 02139
Description
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. The company primarily operates only in the United States. The company has developed a suite of integrated technologies that comprise a Translational Science Platform, enabling it to comprehensively interrogate the cellular and molecular composition of tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 12.13
Equity-to-Asset 0.88
Debt-to-Equity 0.07
Debt-to-EBITDA -0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.94
Distress
Grey
Safe
Beneish M-Score -3.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.58
9-Day RSI 30.03
14-Day RSI 31.02
6-1 Month Momentum % -48.09
12-1 Month Momentum % -39.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.87
Quick Ratio 9.87
Cash Ratio 9.31
Days Sales Outstanding 359.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.9

Financials (Next Earnings Date:2022-08-05 Est.)

JNCE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:JNCE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 25.368
EPS (TTM) ($) -1.98
Beta 0.19
Volatility % 62.05
14-Day RSI 31.02
14-Day ATR ($) 0.284937
20-Day SMA ($) 3.33
12-1 Month Momentum % -39.92
52-Week Range ($) 2.76 - 9.81
Shares Outstanding (Mil) 51.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Jounce Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More